Moreover, the increase in cytoplasmic TDP-43 with aging could serve as an age-related mediator of inflammation and neuronal injury, with the potential for therapeutic targeting of cytoplasmic TDP-43 post stroke that could modulate post-ischemic inflammation and protect damaged neurons in the ischemic microenvironment [161]. The gene discussed is TARDBP; the disease is stroke disorder.